Anbio Biotechnology: xbrl:IncreaseDecreaseInAccountsReceivable

Value{"amount": -717500, "currency": "USD"}
Period2022-01-01 – 2022-12-31
Statuscurrent
EntityAnbio Biotechnology
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001213900-25-035802
Retrieved: 2026-08-19T19:02:33.643442+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Cite as: FACTANKER, https://factanker.com/fact/428d3226-3ccd-49aa-a659-2939a80c051d

History